Melbourne, FL – July 3, 2019 – The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia research. The ultimate goal of this grant program is to drive research that will eliminate the delivery of pre-term babies as an intervention for severe preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy. Named for the infant son of preeclampsia survivor Lauren Pappas and her husband Clement, the program seeks to award multiple grants totaling up to $200,000 each year.
Investigators meeting the program’s criteria are invited to submit Letters of Intent for 2020 proposals by August 16, 2019. Letters of Intent that are of interest to the scientific review committee and the Preeclampsia Foundation’s Board of Directors will then be invited to submit full applications by October 7, 2019 with award decisions rendered in early December 2019.
In addition to meeting the fund’s goals, preference will be given to proposals that use or build upon data available through the Preeclampsia Registry™ (self-reported, whole exome sequenced, and clinical data), or that will produce data or biological materials that can be added to the Registry’s data/bio repository. In addition to utilizing the Registry and its rich assets, proposals must align with the Preeclampsia Foundation’s vision of a world where preeclampsia no longer threatens the lives of mothers and their babies. Examples of such proposals include but are not limited to mechanisms for improved diagnosis or prediction and therapeutic interventions to halt, reverse, or prevent the placental and organ dysfunction associated with the condition.
“Four years ago we lost our son Peter due to preeclampsia following a 29-week delivery,” explained Lauren Pappas. “Since then we have dedicated our lives to helping others avoid the same outcome by establishing the Peter Joseph Pappas Fund.”
“Thanks to generous contributions from family and friends, and our partnership with the Preeclampsia Foundation, we are making strides to reach our ultimate goal of eliminating pre-term births due to preeclampsia by 2050,” added Clement Pappas.
The Peter Joseph Pappas Research Grants program adds to the Preeclampsia Foundation’s portfolio of research programs including the Vision Grant program for young investigators,
PRIME for health services research, EMPOWER, which helps build research capacity in low- and middle-income countries, and the Preeclampsia Registry, a dynamic database of research participants including preeclampsia and HELLP syndrome survivors, family members, and controls (unaffected individuals).
Letters of intent are due by Friday, August 16, 2019, via email to PJPGrants@preeclampsia.org
About the Preeclampsia Foundation
The Preeclampsia Foundation is a U.S.-based 501(c)(3) not-for-profit organization established in 2000. Its purpose is to improve the outcomes of hypertensive disorders of pregnancy by educating, supporting and engaging the community, improving healthcare practices, and finding a cure. The Preeclampsia Foundation envisions a world where hypertensive disorders of pregnancy no longer threaten the lives of mothers and their babies. For more information, visit www.preeclampsia.org.
About the Peter Joseph Pappas Fund
Clement and Lauren Pappas of Philadelphia, PA, lost their firstborn child, Peter Joseph, after HELLP syndrome necessitated his early delivery. Their son, born at 29 weeks’ gestation, spent a week in the neonatal intensive care unit before dying from a central line infection. The Pappas family, along with friends and family, have established a special fund with the Preeclampsia Foundation to advance research, with the overarching goal of eliminating pre-term births due to preeclampsia by 2050.
About The Preeclampsia Registry
The first of its kind to focus solely on hypertensive disorders of pregnancy, The Preeclampsia Registry captures self-reported and clinical information (medical records) as well as family and pregnancy history, and DNA. Overseen by an Institutional Review Board, the Registry ensures participants’ privacy and rights in medical research. The Registry only shares de-identified information with approved scientists, researchers, and clinicians. Launched in 2013, it currently includes over 5,000 participants from every state in the nation as well as dozens of countries around the world.
The Preeclampsia Foundation published research results.
Answers to our most frequently asked questions about the registry
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
According to the World Health Organization, preeclampsia is one of the least funded areas of research, especially when considered against Disability Adjusted Life Years (DALYs). The Preeclampsia Found...
RESEARCH FUNDING Peter Joseph Pappas Research Grant Program July 2022 - The 2023 Peter Joseph Pappas Research Grant application cycle is currently open. Named for the infant son of preeclampsia...
Question: Progesterone supplementation - first trimester and beyond - can it help the vascular constriction by keeping the smooth muscle relaxed (17HP shots), and is it associated with early supplemen...
The Preeclampsia Foundation is seeking Letters of Intent for the Peter Joseph Pappas Research Grants funding program, designed to accelerate preeclampsia research. The ultimate goal of this gran...
Promising New Test May Help to Rule-Out Suspected Preeclampsia in At-Risk Pregnant Women To diagnose preeclampsia, healthcare providers rely on measurable signs: a woman’s blood pressure, the...
Planned delivery or expectant management in preeclampsia: an individual participant data meta-analysis Delivery of the baby and the placenta is still the only definitive management for preeclampsia...
Cardiovascular Risk Factors Mediate the Long-Term Maternal Risk Associated With Hypertensive Disorders of Pregnancy Experiencing a hypertensive disorder of pregnancy increases risk for cardiovascul...